
Next-Generation Sequencing (NGS)-Based Clinical Testing is Recommended for the Detection of Gene Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia Predisposition Syndromes
Author(s) -
Ryan S. Robetorye
Publication year - 2017
Publication title -
journal of next generation sequencing and applications
Language(s) - English
Resource type - Journals
ISSN - 2469-9853
DOI - 10.4172/2469-9853.1000153
Subject(s) - myeloid leukemia , myelodysplastic syndromes , medicine , dna sequencing , gene , genetic testing , myeloid , gene mutation , mutation , genetics , bioinformatics , cancer research , biology , immunology , bone marrow